Emergent BioSolutions
EBS
#6766
Rank
โ‚น57.07 B
Marketcap
โ‚น1,070
Share price
-1.24%
Change (1 day)
38.06%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: โ‚น57.07 Billion

As of December 2025 Emergent BioSolutions has a market cap of โ‚น57.07 Billion. This makes Emergent BioSolutions the world's 6766th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น57.07 B48.47%
2024โ‚น38.44 B270.83%
2023โ‚น10.36 B-78.74%
2022โ‚น48.75 B-71.99%
2021โ‚น174.06 B-49.88%
2020โ‚น347.29 B74.61%
2019โ‚น198.90 B-6.28%
2018โ‚น212.22 B43.35%
2017โ‚น148.04 B63.81%
2016โ‚น90.37 B-13.74%
2015โ‚น104.77 B61%
2014โ‚น65.07 B25.11%
2013โ‚น52.01 B65.13%
2012โ‚น31.50 B-1.64%
2011โ‚น32.02 B-12.98%
2010โ‚น36.80 B89.31%
2009โ‚น19.44 B-48.23%
2008โ‚น37.55 B535.61%
2007โ‚น5.90 B-56.69%
2006โ‚น13.64 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Emergent BioSolutions was reported to be:

โ‚น56.20 Billion
by Nasdaq info icon info icon
โ‚น57.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
โ‚น22.391 T 39,132.57%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น39.91 B-30.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.784 T 15,291.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚น175.92 B 208.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.304 T 23,211.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.935 T 5,042.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
โ‚น1.45 B-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA